A decrease in the levels of this protein in RA may predispose these patients to continued inflammation, along with the dysregulation of lipid and glucose metabolism and increased levels of resting mast cells, CD8 T cells, and follicular helper T cells [51], a characteristic feature of RA. The gene discussed is CD8A; the disease is rheumatoid arthritis.